16.69
-0.02(-0.12%)
Currency In USD
| Previous Close | 16.71 |
| Open | 16.5 |
| Day High | 16.76 |
| Day Low | 16.3 |
| 52-Week High | 73 |
| 52-Week Low | 15.67 |
| Volume | 455,726 |
| Average Volume | 825,827 |
| Market Cap | 676.07M |
| PE | -3.2 |
| EPS | -5.22 |
| Moving Average 50 Days | 53.27 |
| Moving Average 200 Days | 53.34 |
| Change | -0.02 |
Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial
GlobeNewswire Inc.
Dec 12, 2024 11:00 AM GMT
Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company
Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition
GlobeNewswire Inc.
Dec 10, 2024 12:30 AM GMT
Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden, with a median duration of response of 134.1 weeksDurable clinical responses were associated with
Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept
GlobeNewswire Inc.
Dec 03, 2024 12:00 PM GMT
Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to exceed $1.1 billion and tiered royalties on net sales LEXINGTON, Mass., Dec. 03, 2
If you invested $1000 in Keros Therapeutics, Inc. (KROS) since IPO date, it would be worth $823.21 as of December 26, 2024 at a share price of $16.53. Whereas If you bought $1000 worth of Keros Therapeutics, Inc. (KROS) shares 3 years ago, it would be worth $281.65 as of December 26, 2024 at a share price of $16.53.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.